Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer

Autor: Greco, Carlo, Pares, Oriol, Pimentel, Nuno, Louro, Vasco, Nunes, Beatriz, Kociolek, Justyna, Marques, João, Fuks, Zvi

Publikováno v: In Radiotherapy and Oncology April 2022 169:35-42

Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy

Autor: Greco, Carlo, Stroom, Joep, Vieira, Sandra, Mateus, Dalila, Cardoso, Maria João, Soares, Ana, Pares, Oriol, Pimentel, Nuno, Louro, Vasco, Nunes, Beatriz, Kociolek, Justyna, Fuks, Zvi

Publikováno v: In Radiotherapy and Oncology July 2021 160:240-249

The evolving role of external beam radiotherapy in localized prostate cancer

Autor: Greco, Carlo, Vazirani, Anuraag A, Pares, Oriol, Pimentel, Nuno, Louro, Vasco, Morales, Javier, Nunes, Beatriz, Vasconcelos, Ana Luisa, Antunes, Ines, Kociolek, Justyna, Fuks, Zvi

Publikováno v: In Seminars in Oncology June 2019 46(3):246-253

1214: Predictors of successful response to SBRT in PSMA PET/CT staged oligorecurrent prostate cancer

Autor: Soeterik, Timo F.W., Miszczyk, Marcin, Kociolek, Justyna, Greco, Carlo, Francolini, Giulio, Garlatti, Pietro, Bilski, Mateusz, Huele, Eline H., Verkooijen, Helena M., van der Voort van Zyp, Jochem R.N., Eppinga, Wietse, van der Velden, Joanne M.

Publikováno v: In Radiotherapy and Oncology May 2024 194 Supplement 1:S2409-S2410

Positron Emission Tomography-Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy.

Autor: Greco C; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Pares O; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Pimentel N; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Louro V; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Morales J; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Nunes B; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Antunes I; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Vasconcelos AL; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Kociolek J; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Castanheira J; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Oliveira C; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Silva A; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Vaz S; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Oliveira F; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Carrasquinha E; Computational Clinical Imaging Group, Champalimaud Centre for the Unknown, Lisbon, Portugal., Costa D; Department of Nuclear Medicine-Radiopharmacology, Champalimaud Centre for the Unknown, Lisbon, Portugal., Fuks Z; Department of Radiation Oncology, Champalimaud Centre for the Unknown, Lisbon, Portugal.; Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: Advances in radiation oncology [Adv Radiat Oncol] 2021 Dec 05; Vol. 7 (2), pp. 100864. Date of Electronic Publication: 2021 Dec 05 (Print Publication: 2022).